跳至主要内容
临床试验/NCT05428371
NCT05428371尚未招募不适用

A Novel, Multimodal, Machine-learning Grounded Approach to Assess the Oncological Risk of Indeterminate Thyroid Nodules

University of Cagliari1 个研究点 分布在 1 个国家目标入组 256 人开始时间: 2023年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
256
试验地点
1
主要终点
Identification of biomarkers of thyroid carcinoma

研究概览

简要总结

Indeterminate thyroid nodules have a mild risk of malignancy (15-30%). The aim of our study is to individuate new biomarkers of thyroid carcinoma through multiomic analyses of blood samples and of specimen samples of patients with indeterminate thyroid nodules.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with indeterminate thyroid nodules (Class III and Class IV according to Bethesda Classification of thyroid nodules)

排除标准

  • Patients with concomitant thyroid nodules of Bethesda Class V or Class VI
  • Patients with preoperative diagnosis of lymph node metastases of central or lateral neck compartment
  • Patients with distant metastases

结局指标

主要结局

Identification of biomarkers of thyroid carcinoma

时间窗: 50 months

Identification of alterations in cfDNA length and integrity, presence of SNPs in cfDNA, alterations of serum proteome predictive of thyroid carcinoma

次要结局

  • Elaboration of diagnostic algorithm(60 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fabio Medas

Associate Professor

University of Cagliari

研究点 (1)

Loading locations...

相似试验